CD33 and SHP-1/
Alzheimer’s disease
CD33
SHP-1
microglia
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
13 Sep 2024
13 Sep 2024
Historique:
received:
01
07
2024
revised:
04
09
2024
accepted:
11
09
2024
medline:
29
9
2024
pubmed:
28
9
2024
entrez:
28
9
2024
Statut:
epublish
Résumé
Large-scale genetic studies have identified numerous genetic risk factors that suggest a central role for innate immune cells in susceptibility to Alzheimer's disease (AD). CD33, an immunomodulatory transmembrane sialic acid binding protein expressed on myeloid cells, was identified as one such genetic risk factor associated with Alzheimer's disease. Several studies explored the molecular outcomes of genetic variation at the
Identifiants
pubmed: 39336795
pii: genes15091204
doi: 10.3390/genes15091204
pii:
doi:
Substances chimiques
Sialic Acid Binding Ig-like Lectin 3
0
Protein Tyrosine Phosphatase, Non-Receptor Type 6
EC 3.1.3.48
CD33 protein, human
0
PTPN6 protein, human
EC 3.1.3.48
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIH HHS
ID : P30AG066462; RF1AG058852;R01AG043617;F30AG074618;T32AI148099; P30AG10161, P30AG72975; R01AG15819; R01AG17917; U01AG46152; and U01AG61356
Pays : United States